Adherence in antiretroviral therapy: a review of qualitative studies
High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells
Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells
Upregulation of expression of platelet-derived growth factor and its receptor in pneumonia associated with SHIV-infected macaques
Is HIV-2- induced AIDS different from HIV-1-associated AIDS? Data from a West African clinic
Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen
Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa
Modelling the impact of migration on the HIV epidemic in South Africa
Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia
Balancing effectiveness and access to HIV treatment in the developing world
Discontinuation of secondary prophylaxis against penicilliosis marneffei in AIDS patients after HAART
Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patients
Stable pattern of HIV-1 subtype C Gag-specific T-cell responses coincides with slow rate of CD4 T-cell decline in HIV-infected Ethiopians
Tuberculous meningitis in HIV-infected patients: drug susceptibility and clinical outcome
Specificity of anti-human leukocyte antigen antibody responses after immunization with Remune, an inactivated HIV-1 vaccine
Dynamics of HIV viral load in blood and semen of patients under HAART: impact of therapy in assisted reproduction procedures
A new presentation of immune reconstitution inflammatory syndrome followed by a severe paradoxical reaction in an HIV-1-infected patient with tuberculous meningitis
Truvada intolerance
Successful drug treatment of immune reconstitution disease with the leukotriene receptor antagonist, montelukast: a clue to pathogenesis?
Considerations on the increase in blood pressure among antiretroviral-naive patients starting HAART
Schistosomal colonic polyposis in an HIV-positive man
Reply to Ouattara et al.: past history of tuberculosis is not a risk factor for incident tuberculosis during antiretroviral treatment in South Africa
Are a past history of tuberculosis and WHO clinical stage associated with incident tuberculosis in adults receiving antiretroviral therapy?, reply to Lawn et al.
Conventional tuberculin skin testing versus T-cell-based assays in the diagnosis of latent tuberculosis infection in HIV-positive patients
Scaling up HAART in Mexico. Response to Volkow et al.
Reactivation of hepatitis B virus replication during peginterferon–ribavirin therapy in an HIV/hepatitis C virus-co-infected patient with isolated anti-hepatitis B core antibodies